UBS Group’s Trulieve Cannabis Corp TRLV Stock Holding History

UBS Group’s Portfolio TRLV Stock Details TRLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.33K	Buy	+339	New	+$3.27K	﹤0.01%	9205

Other funds holding TRLV

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

ING Group Amsterdam, Netherlands $20.5B AUM 49.71% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

IGAM

iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

UBS Group's TRLV Position: Q2 2026 in Review

UBS Group opened a new position in Trulieve Cannabis Corp (TRLV) in Q2 2026: 339 shares worth $3.33K. The stake represents ﹤0.01% of the portfolio and ranks #9205 among its holdings.

125 funds tracked by Wall St. Rank hold TRLV as of Q2 2026.

UBS Group held 339 shares of Trulieve Cannabis Corp worth $3.33K as of Q2 2026.
Trulieve Cannabis Corp was a new UBS Group position in Q2 2026.
Trulieve Cannabis Corp made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9205 holding.
125 funds tracked by Wall St. Rank held Trulieve Cannabis Corp as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.